Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3391 AL 3405

Parkinson-ALS with a novel MAPT variant

Ferrari C, Ingannato A, Matà S, Ramat S, Caremani L, Bagnoli S, Bessi V, Sorbi S, Nacmias B.

Neurol Sci. 2024 Mar;45(3):1051-1055. doi: 10.1007/s10072-023-07081-4. Epub 2023 Sep 20.

Novel Pyrazolopyridine Inhibitors of Monoacylglycerol Lipase for the Treatment of Neurodegenerative Diseases and Neuroinflammation

Rosse G.

ACS Med Chem Lett. 2024 Jan 2;15(1):19-20. doi: 10.1021/acsmedchemlett.3c00548. eCollection 2024 Jan 11.

Olfactory dysfunction and its related molecular mechanisms in Parkinson's disease

Gu Y, Zhang J, Zhao X, Nie W, Xu X, Liu M, Zhang X.

Neural Regen Res. 2024 Mar;19(3):583-590. doi: 10.4103/1673-5374.380875.

Research progress of cell treatment strategy in Parkinson's disease

Peng YL, Chen J, Hu H, Liu W, Liang W, Wang J.

Neurosci Appl. 2024 Mar 30;3:104061. doi: 10.1016/j.nsa.2024.104061. eCollection 2024.

Setting the clinical context to non-motor symptoms reflected by Park-pain, Park-sleep, and Park-autonomic subtypes of Parkinson's disease

Qamar MA, Tall P, van Wamelen D, Wan YM, Rukavina K, Fieldwalker A, Matthew D, Leta V, Bannister K, Chaudhuri KR.

Int Rev Neurobiol. 2024;174:1-58. doi: 10.1016/bs.irn.2023.08.012. Epub 2023 Dec 1.

Selenium-containing compounds: a new hope for innovative treatments in Alzheimer's disease and Parkinson's disease

Pyka P, Garbo S, Fioravanti R, Jacob C, Hittinger M, Handzlik J, Zwergel C, Battistelli C.

Drug Discov Today. 2024 Aug;29(8):104062. doi: 10.1016/j.drudis.2024.104062. Epub 2024 Jun 11.

The role of gut-derived short-chain fatty acids in Parkinson's disease

Saadh MJ, Mustafa AN, Mustafa MA, S RJ, Dabis HK, Prasad GVS, Mohammad IJ, Adnan A, Idan AH.

Neurogenetics. 2024 Oct;25(4):307-336. doi: 10.1007/s10048-024-00779-3. Epub 2024 Sep 13.

Alpha-Synuclein and Microglia in Parkinson's Disease: From Pathogenesis to Therapeutic Prospects

Eo H, Kim S, Jung UJ, Kim SR.

J Clin Med. 2024 Nov 28;13(23):7243. doi: 10.3390/jcm13237243.

Sublingual apomorphine in the treatment of Parkinson's disease

Kassubek J, Jost WH, Schwarz J.

J Neural Transm (Vienna). 2024 Oct;131(10):1209-1216. doi: 10.1007/s00702-024-02777-z. Epub 2024 May 14.

Decoding the Role of Nuclear Sirtuins in Parkinson's Pathogenesis

Patel D, Soni R, Shah J.

ACS Chem Neurosci. 2024 Sep 27. doi: 10.1021/acschemneuro.4c00507. Online ahead of print.

Challenges of equitable access to device-aided therapies for advanced Parkinson's Disease in Poland - expert consensus and treatment recommendations

Popławska-Domaszewicz K, Siuda J, Rudzińska-Bar M, Budrewicz S, Koziorowski D, Bogucki A, Chaudhuri KR, Sławek J.

Neurol Neurochir Pol. 2024;58(6):608-616. doi: 10.5603/pjnns.102680.

The why and how of the SynNerGe criteria of Parkinson´s disease

Höglinger GU, Lang AE.

J Neural Transm (Vienna). 2024 Oct;131(10):1149-1154. doi: 10.1007/s00702-024-02797-9. Epub 2024 Jun 25.

An Alternative Approach for the Rehabilitation of a Complete Denture Patient With Parkinson's Disease

Priya M, Dubey SA, Gorripati JP.

Cureus. 2024 Aug 7;16(8):e66406. doi: 10.7759/cureus.66406. eCollection 2024 Aug.

Modulation of time in Parkinson's disease: a review and perspective on cognitive rehabilitation

Honma M, Terao Y.

Front Psychiatry. 2024 Apr 15;15:1379496. doi: 10.3389/fpsyt.2024.1379496. eCollection 2024.

Cognitive dysfunction in animal models of human lewy-body dementia

Haikal C, Winston GM, Kaplitt MG.

Front Aging Neurosci. 2024 Jul 22;16:1369733. doi: 10.3389/fnagi.2024.1369733. eCollection 2024.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias